Related Experiment Videos
Management of hyperlipidaemia
Insights
Hyperlipidaemia management in adults involves dietary changes and, if needed, medication. Treatment strategies depend on the specific lipid profile pattern for effective cardiovascular disease prevention.
Area of Science:
- Clinical Medicine
- Cardiology
- Endocrinology
Background:
- Hypercholesterolaemia is prevalent in Singapore, linked to cardiovascular disease.
- Abnormal lipid levels include high low-density lipoprotein (LDL) cholesterol, low high-density lipoprotein (HDL) cholesterol, and hypertriglyceridaemia.
Purpose of the Study:
- To discuss the clinical management of adult hyperlipidaemia.
- To outline practical approaches based on four distinct hyperlipidaemia patterns.
Main Methods:
- Classification of hyperlipidaemia into four patterns: isolated hypercholesterolaemia, moderate hypertriglyceridaemia, combined hyperlipidaemia, and severe hypertriglyceridaemia.
- Emphasis on aetiopathogenetic diagnosis to identify underlying causes (genetic or secondary diseases).
- Dietary recommendations: low cholesterol, low fat (especially saturated fat), with stricter fat reduction for severe cases.
- Pharmacological therapy as a secondary treatment when lifestyle modifications are insufficient.
- Drug selection tailored to the specific hyperlipidaemia pattern, with potential need for combination therapy.
Main Results:
- Dietary modification is a cornerstone for all hyperlipidaemia patterns.
- Pharmacological intervention is necessary for patients not reaching lipid targets.
- Treatment choice depends on the hyperlipidaemia pattern.
- Caution advised with combined drug therapy due to potential potentiation of side-effects.
Conclusions:
- Effective hyperlipidaemia management requires pattern-specific strategies.
- Identifying and treating underlying conditions can resolve hyperlipidaemia.
- A combination of diet and pharmacotherapy, used cautiously, is key to managing adult hyperlipidaemia and reducing cardiovascular risk.
Abstract:
Recent community-based studies have shown that hypercholesterolaemia is common in Singapore. High low-density lipoprotein (LDL) cholesterol, low high-density lipoprotein (HDL) cholesterol as well as hypertriglyceridaemia are associated with higher prevalence of cardiovascular disease. The aim of this article is to discuss the clinical management of adult patients with hyperlipidaemia. For practical purposes, the hyperlipidaemias can be divided into four patterns: 1) hypercholesterolaemia with normal triglyceride, 2) moderate hypertriglyceridaemia with normal cholesterol, 3) combined moderate hypercholesterolaemia and hypertriglyceridaemia, and 4) severe hypertriglyceridaemia with moderate hypercholesterolaemia. Each pattern can be attributed primarily to genetic conditions or secondarily to common diseases. It is important to attempt aetiopathogenetic diagnosis for each hyperlipidaemic patient as treatment of an underlying condition may sometimes reverse the hyperlipidaemia eg hypothyroidism and hypercholesterolaemia. In general, a low cholesterol and low fat (particularly saturated fat) diet is useful in patients with all four patterns of hyperlipidaemia. Patients with severe hypertriglyceridaemia and moderate hypercholesterolaemia may benefit from a further drastic reduction in fat intake. Pharmacological therapy is required for patients who do not achieve target lipid levels after diet modification. The choice of drug therapy is, to a large extent, dependent on the pattern of hyperlipidaemia. In some situations, combination drug therapy may be required. Caution is required in combining hypolipidaemic drugs as the side-effects of individual drugs may be potentiated when used in combination.